Rapid detection of SARS-CoV-2 B.1.1.529 (Omicron BA.1) variant by SYBR Green□based RT□qPCR
Rattachement africain : lb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of 10 samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Rapid detection of SARS-CoV-2 B.1.1.529 (Omicron BA.1) variant by SYBR Green□based RT□qPCR
- Date Crossref
- 17/05/2023
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Lebanese University pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of science I Laboratory of Molecular Biology and Cancer Immunology (Covid 19 Unit) pays non établi dans la noticeUniversité ou école supérieure
Lebanese University et Laboratory of Molecular Biology and Cancer Immunology (Covid 19 Unit) — Faculty of science I.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.